Cellular senescence as a therapeutic target for aging intervention

Youkun Bi and Guangju Ji

Biomedical Journal, 2026, 100948
DOI: 10.1016/j.bj.2026.100948

Targeting ferroptosis with natural products: Investigating promising agents for treating diabetes and its complications

Bi-Tiao He, Yue Yun, Qian-Ru Lin, Xu-Han Liu and Yu-Dan Liu

Biomedicine & Pharmacotherapy, 2025, 189, 118304
DOI: 10.1016/j.biopha.2025.118304

Beneficial effects of flavonoids on cardiovascular diseases by influencing NLRP3 inflammasome

Hai-yan Fang, Xiao-ni Zhao, Meng Zhang, Yao-yao Ma, Jin-ling Huang and Peng Zhou

Inflammopharmacol, 2023, 31, 1715
DOI: 10.1007/s10787-023-01249-2

The progression from mild to severe hyperglycemia coupled with insulin resistance causes mitochondrial dysfunction and alters the metabolic secretome of epithelial kidney cells

Patrícia C. Braga, Raquel L. Bernardino, Bárbara Guerra-Carvalho, David F. Carrageta, Pedro F. Oliveira, Anabela S. Rodrigues and Marco G. Alves

Experimental Cell Research, 2023, 431, 113744
DOI: 10.1016/j.yexcr.2023.113744

SB-525334 ameliorates renal injury in diabetic kidney disease mouse model via suppressing inflammation

Jianheng Chen, Tao Wang, Jiang Zhu, Yuhang Gong and Jie Song

The American Journal of the Medical Sciences, 2024, 368, 369
DOI: 10.1016/j.amjms.2024.06.009

Relevance of the Pyroptosis-Related Inflammasome Pathway in the Pathogenesis of Diabetic Kidney Disease

Pan Liu, Zhengdong Zhang and Yao Li

Front. Immunol., 2021, 12
DOI: 10.3389/fimmu.2021.603416

Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome

Wenmin Dong, Chenglin Jia, Ji Li, Yi Zhou, Yun Luo, Jibo Liu, Zhiguo Zhao, Jiaqi Zhang, Shan Lin and Ying Chen

Front. Pharmacol., 2022, 13
DOI: 10.3389/fphar.2022.783706

Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease

Yan Wang, Zhun Sui, Mi Wang and Peng Liu

Front. Immunol., 2023, 14
DOI: 10.3389/fimmu.2023.1196016

Juglanin alleviates bleomycin-induced lung injury by suppressing inflammation and fibrosis via targeting sting signaling

Shi-Chao Sun, Ru Han, Shuang-Shuang Hou, Hua-Qiang Yi, Shou-Jun Chi and Ai-Hua Zhang

Biomedicine & Pharmacotherapy, 2020, 127, 110119
DOI: 10.1016/j.biopha.2020.110119

Fisetin attenuates renal ischemia/reperfusion injury by improving mitochondrial quality, reducing apoptosis and oxidative stress

Priyanka N. Prem and Gino A. Kurian

Naunyn-Schmiedeberg's Arch Pharmacol, 2022, 395, 547
DOI: 10.1007/s00210-022-02204-8

Unraveling the role of RIPKs in diabetic kidney disease and its therapeutic perspectives

Anju Ambujakshan and Bidya Dhar Sahu

Biochemical Pharmacology, 2025, 231, 116642
DOI: 10.1016/j.bcp.2024.116642

Tirzepatide Ameliorates Renal Dysfunction, Dyslipidemia, and Thyroid Hormone Dysregulation in Diabetic Rats

Amal M. AlRashidi and Ahmad H. Alhowail

Int. J. Pharmacol., 2026, 22
DOI: 10.31083/IJP49432

Fisetin is a selective adenosine triphosphate‐competitive inhibitor for mitogen‐activated protein kinase kinase 4 to inhibit lipopolysaccharide‐stimulated inflammation

Ziyu He, Takuhiro Uto, Shunsuke Tanigawa, Kozue Sakao, Takuma Kumamoto, Kun Xie, Xuchi Pan, Shusong Wu, Yili Yang, Masaharu Komatsu and De‐Xing Hou

BioFactors, 2025, 51
DOI: 10.1002/biof.2108

Loss of RIP3 alleviates insulin resistance and inflammation in gestational diabetes mellitus mice via TLR4/MyD88/NF-κB signaling pathway

Yingying He, Weiwei Zhu, Yuebo Qiu and Kening Zhou

BMC Pregnancy Childbirth, 2025, 25
DOI: 10.1186/s12884-025-07217-8

Circ ASAP2 decreased inflammation and ferroptosis in diabetic nephropathy through SOX2/SLC7A11 by miR-770-5p

Qin Li, Xiangjian Meng and Qiang Hua

Acta Diabetol, 2022, 60, 29
DOI: 10.1007/s00592-022-01961-5

Recent advances in potential of Fisetin in the management of myocardial ischemia-reperfusion injury–A systematic review

Priyanka N. Prem, Bhavana Sivakumar, Sri Rahavi Boovarahan and Gino A. Kurian

Phytomedicine, 2022, 101, 154123
DOI: 10.1016/j.phymed.2022.154123

Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice

Qian Ren, Fan Guo, Sibei Tao, Rongshuang Huang, Liang Ma and Ping Fu

Biomedicine & Pharmacotherapy, 2020, 122, 109772
DOI: 10.1016/j.biopha.2019.109772

Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling

Qian Ren, Sibei Tao, Fan Guo, Bo Wang, Letian Yang, Liang Ma and Ping Fu

Phytomedicine, 2021, 87, 153552
DOI: 10.1016/j.phymed.2021.153552

Effect and mechanism of fisetin against the development of metabolic dysfunction-associated fatty liver disease

Xin Peng, Zhiheng Wei, Shihao Liu, Luojie Liu, Honglin Jiang, Lisha Yu, Xiaodan Xu and Zhiliang Gu

Sci Rep, 2025, 15
DOI: 10.1038/s41598-025-96848-0

Emerging Therapeutic Potential of Fisetin for Nephrotoxicity, Kidney Injury, and Nephropathy: A Systematic Review

Saeed Mohajeri, Alizamen Salehifard Jouneghani, Saeid Heidari-Soureshjani, Catherine MT Sherwin and Faramarz Beigi

CDR, 2026, 22
DOI: 10.2174/0115733998369114250512094027

Fisetin protects against renal injury and fibrosis evoked by diesel particulate matter via downregulation of IL-23/mTOR/S6K-b1 signaling and caveolin-1 expression in rats

Yasmin K. Mahmoud, Hoda E. Mohamad, Ahmed A. Hasan, Hager Y. Mohamed and Omer I. Fantoukh

Appl Biol Chem, 2026, 69
DOI: 10.1186/s13765-025-01072-z

Juglanin protects against high fat diet-induced renal injury by suppressing inflammation and dyslipidemia via regulating NF-κB/HDAC3 signaling

Qiang Li, Chenxu Ge, Jun Tan, Yan Sun, Qin Kuang, Xianling Dai, Shaoyu Zhong, Chao Yi, Lin-Feng Hu, De-Shuai Lou and Minxuan Xu

International Immunopharmacology, 2021, 95, 107340
DOI: 10.1016/j.intimp.2020.107340

The protective effects of fisetin in metabolic disorders: a focus on oxidative stress and associated events

Mahboobe Sattari, Jamal Amri, Mohammad Esmaeil Shahaboddin, Mohadese Sattari, Ozra Tabatabaei-Malazy, Marzyeh Azmon, Reza Meshkani and Ghodratollah Panahi

J Diabetes Metab Disord, 2024, 23, 1753
DOI: 10.1007/s40200-024-01502-7

Flavonoids improve type 2 diabetes mellitus and its complications: a review

Xinrui Yi, Mosi Dong, Naifei Guo, Jinlong Tian, Ping Lei, Song Wang, Yufeng Yang and Yan Shi

Front. Nutr., 2023, 10
DOI: 10.3389/fnut.2023.1192131

Therapeutic Potential and Molecular Mechanisms of the Multitargeted Flavonoid Fisetin

Abdur Rauf, Tareq Abu-Izneid, Muhammad Imran, Hassan A. Hemeg, Kashif Bashir, Abdullah S.M. Aljohani, Mona S.M. Aljohani, Fahad A. Alhumaydhi, Ishaq N. Khan, Talha Bin Emran, Tanweer Aslam Gondal, Nikhil Nath, Ishtiaque Ahmad and Muthu Thiruvengadam

CTMC, 2023, 23, 2075
DOI: 10.2174/1568026623666230710162217

Dietary Phytochemicals that Can Extend Longevity by Regulation of Metabolism

Jie Shen, Jianying Shan, Lichao Zhong, Boying Liang, Dake Zhang, Motao Li and Hao Tang

Plant Foods Hum Nutr, 2022, 77, 12
DOI: 10.1007/s11130-021-00946-z

Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)

Chaima Mouffouk, Soumia Mouffouk, Sara Mouffouk, Leila Hambaba and Hamada Haba

European Journal of Pharmacology, 2021, 891, 173759
DOI: 10.1016/j.ejphar.2020.173759

Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway

Jun-Liang Pu, Zuo-Tian Huang, Yun-Hai Luo, Tong Mou, Ting-Ting Li, Zhong-Tang Li, Xu-Fu Wei and Zhong-Jun Wu

Hepatobiliary & Pancreatic Diseases International, 2021, 20, 352
DOI: 10.1016/j.hbpd.2021.04.013

NLRP3 Inflammasome in Metabolic-Associated Kidney Diseases: An Update

Wei Xiong, Xian-Fang Meng and Chun Zhang

Front. Immunol., 2021, 12
DOI: 10.3389/fimmu.2021.714340

Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy

Antonio Battaglia-Vieni, Vanessa Marchant, Lucia Tejedor-Santamaria, Cristina García-Caballero, Elena Flores-Salguero, María Piedad Ruiz-Torres, Sandra Rayego-Mateos, Ana Belen Sanz, Alberto Ortiz and Marta Ruiz-Ortega

Pharmaceuticals, 2025, 18, 822
DOI: 10.3390/ph18060822

Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study

Illathu Madhavamenon Krishnakumar, Asha Jaja-Chimedza, Ashil Joseph, Abhilash Balakrishnan, Balu Maliakel and Andrew Swick

J Nutr Sci, 2022, 11
DOI: 10.1017/jns.2022.72

Lycopene-Loaded Bilosomes Ameliorate High-Fat Diet-Induced Chronic Nephritis in Mice through the TLR4/MyD88 Inflammatory Pathway

Chang Liu, Yu Liu, Ciwan Wang, Yahui Guo, Yuliang Cheng, He Qian and Yong Zhao

Foods, 2022, 11, 3042
DOI: 10.3390/foods11193042

Fisetin Ameliorates Diabetic Nephropathy‐Induced Podocyte Injury by Modulating Nrf2/HO‐1/GPX4 Signaling Pathway

Xiaojing Qian, Shan Lin, Ji Li, ChengLin Jia, Yun Luo, Rui Fan, Cheng Hu, Ying Chen and Claudia Di Giacomo

Evidence-Based Complementary and Alternative Medicine, 2023, 2023
DOI: 10.1155/2023/9331546

Molecular Mechanistic Pathways Targeted by Natural Compounds in the Prevention and Treatment of Diabetic Kidney Disease

Kaixuan Zhou, Xue Zi, Jiayu Song, Qiulu Zhao, Jia Liu, Huiwei Bao and Lijing Li

Molecules, 2022, 27, 6221
DOI: 10.3390/molecules27196221

Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis

Shogo Ijima, Yuki Saito, Kentaro Nagaoka, Sena Yamamoto, Tsukasa Sato, Norihiro Miura, Taiki Iwamoto, Maki Miyajima and Takako S. Chikenji

Front. Immunol., 2022, 13
DOI: 10.3389/fimmu.2022.960601

Cellular senescence and metabolic aging in type 2 diabetes: mechanistic insights and translational implications

Ammaar Riyaz Syed, Radwan Abdulaziz Aloti, Bassam Jehad Awad, Wasim Iyad Ibrahim Alghoul, Mohamed Ayman Mohamed Samy Aly Hassan, Ahmad Kharoufeh and Imran Rangraze

Front. Endocrinol., 2026, 17
DOI: 10.3389/fendo.2026.1799261

LINC00323 mediates the role of M1 macrophage polarization in diabetic nephropathy through PI3K/AKT signaling pathway

Kun Li and Qiang Li

Human Immunology, 2021, 82, 960
DOI: 10.1016/j.humimm.2021.08.010

Targeting the NLRP3 inflammasome in kidney disease: molecular mechanisms, pathogenic roles, and emerging small-molecule therapeutics

Yanfang Luo, Muyang Long, Xueqin Wu and Liuting Zeng

Front. Immunol., 2025, 16
DOI: 10.3389/fimmu.2025.1703560

Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats

Shan Shan Qi, Hong Xing Zheng, Hai Jiang, Li Ping Yuan and Le Chen Dong

Biomolecules, 2020, 10, 398
DOI: 10.3390/biom10030398

Omnifarious fruit polyphenols: an omnipotent strategy to prevent and intervene diabetes and related complication?

Yao Chen, Xuejiao Qie, Wei Quan, Maomao Zeng, Fang Qin, Jie Chen, Benu Adhikari and Zhiyong He

Critical Reviews in Food Science and Nutrition, 2023, 63, 4288
DOI: 10.1080/10408398.2021.2000932

Fisetin Ameliorates Hepatocyte Lipid Droplet Accumulation via Targeting the Rhythmic Protein BMAL1 to Regulate Cell Death-Inducing DNA Fragmentation Factor-α-like Effector C-Mediated Lipid Droplet Fusion

Ranran Zhang, Meitong Liu, Jing Lu, Shujing Lu, Yuanmeng Wang and Shuang Guan

J. Agric. Food Chem., 2024, 72, 26884
DOI: 10.1021/acs.jafc.4c06487

Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease

Ting-Ting Chang, Szu-Yuan Li, Liang-Yu Lin, Ching Chen and Jaw-Wen Chen

Biomedicine & Pharmacotherapy, 2023, 161, 114450
DOI: 10.1016/j.biopha.2023.114450

Andrographis paniculataImproves Insulin Resistance in High-Fat Diet-Induced Obese Mice and TNFα-Treated 3T3-L1 Adipocytes

Chih-Chieh Chen, Chong-Kuei Lii, Yi-Hsueh Lin, Pei-Hsin Shie, Ya-Chen Yang, Chin-Shiu Huang and Haw-Wen Chen

Am. J. Chin. Med., 2020, 48, 1073
DOI: 10.1142/S0192415X20500524

LncRNA PVT1 as a Novel Biomarker for Diabetes-related Complications

Xinyan Qiu, Jinlan Chen, Jingjie Yang, Jiahui Hu, Peng Fan and Chengfu Yuan

CMC, 2024, 31, 688
DOI: 10.2174/0929867330666230210103447

Metabolites of traditional Chinese medicine targeting PI3K/AKT signaling pathway for hypoglycemic effect in type 2 diabetes

Yuhan Feng, Yan Ren, Xia Zhang, Songqin Yang, Qian Jiao, Qiuhong Li and Wenwen Jiang

Front. Pharmacol., 2024, 15
DOI: 10.3389/fphar.2024.1373711

Fisetin improves lead-induced neuroinflammation, apoptosis and synaptic dysfunction in mice associated with the AMPK/SIRT1 and autophagy pathway

Wei Yang, Zhi-Kai Tian, Hui-Xin Yang, Zhao-Jun Feng, Jian-Mei Sun, Hong Jiang, Chao Cheng, Qing-Lei Ming and Chan-Min Liu

Food and Chemical Toxicology, 2019, 134, 110824
DOI: 10.1016/j.fct.2019.110824

Identification of diagnostic markers and immune cell infiltration characteristics in antineutrophil cytoplasmic antibody-associated vasculitis by weighted gene co-expression network analysis

Mengdi Xia, Fen Zhao, Yongji Zhang, Zhihuang Zheng, Yun Zhou and Tong Liu

Eur J Med Res, 2022, 27
DOI: 10.1186/s40001-022-00666-3

Mitigation of Insulin Resistance by Natural Products from a New Class of Molecules, Membrane-Active Immunomodulators

Elzbieta Izbicka and Robert T. Streeper

Pharmaceuticals, 2023, 16, 913
DOI: 10.3390/ph16070913

Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1

Liping Wu, Yongcun Liu, Yuan Zhao, Meng Li and Ling Guo

Free Radical Biology and Medicine, 2020, 153, 140
DOI: 10.1016/j.freeradbiomed.2020.04.009

Salidroside from Rhodiola rosea L. attenuates diabetic nephropathy in STZ induced diabetic rats via anti-oxidative stress, anti-inflammation, and inhibiting TGF-β1/Smad pathway

Shan Shan Qi, Meng Li Shao, Sun Ze and Hong Xing Zheng

Journal of Functional Foods, 2021, 77, 104329
DOI: 10.1016/j.jff.2020.104329

NLRP3 Inflammasome: A central player in renal pathologies and nephropathy

Nada T. Henedak, Hanan S. El-Abhar, Ayman A. Soubh and Dalaal M. Abdallah

Life Sciences, 2024, 351, 122813
DOI: 10.1016/j.lfs.2024.122813

Exploring the therapeutic effect of flavonoids on kidney health

Palash Mitra, Sahadeb Jana, Kaberi Kandar, Anwesha Tripathy and Suchismita Roy

Current Pharmaceutical Analysis, 2025, 21, 323
DOI: 10.1016/j.cpan.2025.06.001

Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches

Chetan Ram, Ankush Kumar Jha, Aparajita Ghosh, Shobhit Gairola, Abu Mohammad Syed, Upadhyayula Suryanarayana Murty, V.G.M. Naidu and Bidya Dhar Sahu

European Journal of Pharmacology, 2020, 885, 173503
DOI: 10.1016/j.ejphar.2020.173503

Adiposity Reduction by Cucumis melo var. gaettongchamoe Extract in High-Fat Diet-Induced Obese Mice

Sun Young Park, Ji Eun Kim, He Mi Kang, Hee Jin Song, Nam Jun Kang, Dae Youn Hwang and Young-Whan Choi

Nutrients, 2023, 15, 3292
DOI: 10.3390/nu15153292

Fisetin Prevents Oxidized Low-density Lipoprotein–Induced Macrophage Foam Cell Formation

Johnna F. Varghese, Rohit Patel, Mohit Singh and Umesh C. S. Yadav

Journal of Cardiovascular Pharmacology, 2021, 78, e729
DOI: 10.1097/FJC.0000000000001096